1/8/2023 0 Comments Topcat clinical trial![]() Pitt has been a consultant for Bayer, AstraZeneca, Sanofi, KBP Pharmaceuticals, and Relypsa/Vifor has stock options in KBP Pharmaceuticals, Sarfez, and Relypsa/Vifor and holds a US Patent (9931412). Sweitzer has received research grants from Novartis and Merck. Rouleau has been a consultant for Novartis and AstraZeneca. Desai has received research grants from Novartis and has been a consultant for Novartis, Abbott, AstraZeneca, Relypsa, DalCor Pharma, Amgen, Boston Scientific, and Boehringer Ingelheim. Shah was supported by NHLBI grants K08HL116792 and R01HL135008 has received research support from Novartis and has been a consultant for Philips Ultrasound and Bellerphon. The TOPCAT study was sponsored by the National Heart, Lung, and Blood Institute (NHLBI).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |